Brief: Agenus Reports First Quarter 2026 Financial Results And Highlights Bot+Bal Execution Across Global Access And Phase 3 Development
11/05/2026 14:17
May 11 (Reuters) - Agenus Inc AGEN.O: AGENUS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS BOT+BAL EXECUTION ACROSS GLOBAL ACCESS AND PHASE 3 DEVELOPMENT Source text: ID:nBw3q6DCba Further company coverage: AGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income